Clinical Trial Update: Safety and Efficacy of Adipose Derived Stem Cells in Refractory Rheumatoid Arthritis, Systemic Lupus Erythematosus or Sharp's Syndrome [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating adipose-derived stem cells for safety and efficacy in refractory rheumatoid arthritis, systemic lupus erythematosus, or Sharp's syndr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis
• Sharp Syndrome
• Systemic Lupus Erythematosus

Drugs mentioned

• Adipose-Derived Stem Cells (adipose-derived stem cells)

Snippet

Sponsor: Arkansas Heart Hospital | Conditions: Systemic Lupus Erythematosus, Rheumatoid Arthritis | Phase 1 | Status: TERMINATED